Skip to main content
. 2015 Oct 15;8(10):17418–17429.

Table 3.

Meta-Analysis of PPARG rs1801282 C>G polymorphism with polycystic ovary syndrome risk

No. of study G vs. C GG vs. CC GG+CG vs. CC GG vs. CG+CC CG vs. CC





OR (95% CI) P P (Q-test) OR (95% CI) P P (Q-test) OR (95% CI) P P (Q-test) OR (95% CI) P P (Q-test) OR (95% CI) P P (Q-test)
Total 23 0.78 (0.69-0.89) < 0.001 0.458 0.66 (0.43-1.02) 0.060 0.962 0.77 (0.68-0.89) < 0.001 0.229 0.70 (0.46-1.07) 0.098 0.947 0.79 (0.68-0.91) 0.001 0.122
Ethnicity
    Asians 7 0.72 (0.59-0.88) 0.001 0.112 0.69 (0.36-1.32) 0.264 0.834 0.73 (0.50-1.06) 0.102 0.051 0.74 (0.39-1.41) 0.353 0.788 0.75 (0.49-1.13) 0.165 0.032
    Caucasians 16 0.83 (0.71-0.97) 0.019 0.842 0.64 (0.37-1.14) 0.128 0.871 0.83 (0.70-0.99) 0.033 0.720 0.67 (0.38-1.18) 0.167 0.849 0.85 (0.71-1.01) 0.071 0.595
HWE
    Yes 18 0.76 (0.66-0.88) < 0.001 0.493 0.81 (0.46-1.45) 0.481 0.980 0.74 (0.63-0.86) < 0.001 0.288 0.87 (0.49-1.54) 0.623 0.977 0.73 (0.62-0.86) < 0.001 0.206
    No 5 0.84 (0.66-1.06) 0.134 0.217 0.52 (0.27-0.99) 0.047 0.557 0.89 (0.69-1.16) 0.392 0.163 0.54 (0.29-1.02) 0.059 0.508 0.97 (0.73-1.29) 0.854 0.121

HWE: Hardy-Weinberg equilibrium. Bold values are statistically significant (P < 0.05).